• Skip to primary navigation
  • Skip to main content

Women's Health and Corporate Marketing

Our bodies, their business

  • Home
  • Table of Contents
  • Chapter Resources
    • Chapter 1 Resources
    • Chapter 2 Resources
    • Chapter 3 Resources
    • Chapter 4 Resources
    • Chapter 5 Resources
    • Chapter 6 Resources

doctor

August 1, 2024

US Bows to Lobbyists

The FDA has ruled menthol in cigarettes encourages smoking and harms population health. The current presidential administration has failed to act on this rule as explained in this report.

Filed Under: Chapter 2 Resources

July 31, 2024

Former Purdue Pharma Rep Has Suggestions

Gail Groves Scott, a former drug rep for Purdue Pharma and whistleblower, talks about her role in promoting opioids and subsequently promoting medication to treat addiction. She proposes requiring drug reps to be licensed like other health professionals, identification/disclosure of problem prescribers (“pill mills”), ending abuse of the patent (USPTA) and regulatory (FDA) systems, and prosecuting drug companies for fraudulent claims and violations of the Sunshine Act.

Filed Under: Chapter 3 Resources

July 30, 2024

The Professional Organization’s Role in Marketing Estrogen

The caption for this photo is “Mary finds evidence of corporate influence at a conference.” TherapeuticsMD provides an interesting example of a company’s attempt to enter the lucrative HRT market. This 2017 video reflects the early enthusiasm of investors. After nearly going bankrupt, the company sold its R&D commercial assets, and in 2022 purchased the rights to pharmaceutical royalties that it now sells to investors. Estrogen in any form is a money maker.
 

Filed Under: Chapter 6 Resources

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 7
  • Page 8
  • Page 9

Copyright © 2026 · Hello! Pro 3 on Genesis Framework · WordPress · Log in